Medical Decisions Empowered by Genetics
Revolutionizing Patient Care
For over 25 years Myriad has been revolutionizing how to approach cancer treatment. Being one of the first companies to study and discover the BRCA 1/2 gene association with breast and ovarian cancer, Myriad has been a pioneer for the landscape of patient care.
Myriad Oncology's Tests Are
3 out of 4 patients pay $0 due to excellent coverage and assistance
Industry-leading accuracy so you can feel confident in your patients’ results
Unlike some labs, Myriad will never sell your patients’ personal or genetic information
Myriad makes genetic testing simple with clear, actionable results